《藍籌業績》萬洲國際(00288.HK)上半年生物公允價值調整前淨利潤3.83億美元跌45.4% 派中期息5港仙
萬洲國際(00288.HK)公布截至今年6月底止中期業績,營業額131.16億美元(下同),按年跌2.1%。生物公允價值調整前淨利潤3.83億元,按年跌45.4%,每股基本盈利2.99仙;派中期息5港仙,上年同期派5港仙。
按生物公允價值調整後計算,淨利潤為4.2億元,按年跌44.7%;每股盈利3.27仙。
期內,肉製品及豬肉銷量分別下降0.9%及0.2%,至159.7萬噸及202.6萬噸。總生豬屠宰量維持在2,543萬頭。
展望未來,預期不利的經營環境將繼續在今年的若干期間影響公司。因此,集團的短期財務表現將會承受壓力。為應對該等挑戰,公司將專注完善產業價值鏈,並繼續大力推動產品結構轉型和擴大銷售網絡、管理價格及控制成本,亦將利用自身全球佈局的優勢更好地調配資源,並深化協同效應。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.